I hope that is the case, interesting it performed better with the lower 50mg dose vs the 75mg against the UMSARS endpoint. Anyone have a view why that might be the case?
All will be revealed this year after they meet with the FDA, and if the FDA recommend AA pathway I think that will be my entry point
should find out mid year
goodluck
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 0.9¢ | $103.8K | 10.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 15072426 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 423663 | 2 |
View Market Depth
| Last trade - 16.17pm 30/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |